A detailed history of Stone House Investment Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Stone House Investment Management, LLC holds 100 shares of MRNA stock, worth $4,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 124 19.35%
Holding current value
$4,027
Previous $14,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $1,527 - $3,003
-24 Reduced 19.35%
100 $6,000
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $7,691 - $12,662
-76 Reduced 38.0%
124 $14,000
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $8,110 - $10,966
-95 Reduced 32.2%
200 $21,000
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $5,881 - $7,723
61 Added 26.07%
295 $30,000
Q1 2023

Apr 25, 2023

BUY
$135.66 - $197.02 $31,744 - $46,102
234 New
234 $35,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Stone House Investment Management, LLC Portfolio

Follow Stone House Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone House Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone House Investment Management, LLC with notifications on news.